Beyfortus (Nirsevimab) RSV Antibody — Vax-Before-Travel

Beyfortus (Nirsevimab) RSV Antibody

Fact checked by Robert Carlson, MD

Dec 28

3 min read

Infants Protected From RSV Hospitalizations With Passive Immunization

Beyfortus monoclonal antibody found highly effective in protecting infants from severe RSV

RSV vaccine 2023

Respiratory Syncytial Virus (RSV)

Fact checked by Robert Carlson, MD

Feb 26

3 min read

Infants May Have Additional Protections Against RSV

RSV monoclonal antibody therapy initially approved in 1998

RSV antibody protection

Respiratory Syncytial Virus (RSV)

Fact checked by Robert Carlson, MD

Jan 5

4 min read

Single-Dose RSV Protection for Infants Under Review in U.S.

FDA accepts AstraZeneca nirsevimab application

RSV protection for infants

Respiratory Syncytial Virus (RSV)

Fact checked by Robert Carlson, MD

Nov 4

3 min read

Europe Approves Single-dose RSV Option for Infants

Beyfortus prevents respiratory syncytial virus infections in children

RSV prevention from antibody immunization

Respiratory Syncytial Virus (RSV)

Fact checked by Holly Lutmer PharmD

Sep 17

4 min read

Will Europe Lead RSV Prevention

RSV prevention includes vaccines candidates and antibody treatment

Paris street fair entertainer

Respiratory Syncytial Virus (RSV)